Potomac Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Potomac Health News.

Press releases published on October 7, 2026

5 hours ago

VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods

Indeterminate GlobeNewswire

5 hours ago

Byondis to Profile Potential of Platform Technologies at World ADC San Diego, Advancing Strategy to Lead the Antibody-Drug Conjugate Field

Indeterminate GlobeNewswire

5 hours ago

Rezera Announces Positive RESOLVE-2 Phase 2 Clinical Trial Results Demonstrating Favorable Safety and Tolerability Profile for Ruvonoflast in Combination with Semaglutide

Indeterminate GlobeNewswire

5 hours ago

Pacira BioSciences and Caregiver Action Network Announce New Survey on Gaps in Preparing Families for Postsurgical Recovery at Home

Indeterminate GlobeNewswire

5 hours ago

Bexorg Awarded Up to $28.3 Million from ARPA-H to Advance Human Brain Translational Pharmacology for CNS Drug Development

Indeterminate GlobeNewswire

5 hours ago

AltruBio to Present Data from ALTB-268 Phase 2a Trial on Ulcerative Colitis at United European Gastroenterology (UEG) Week 2026

Indeterminate GlobeNewswire

5 hours ago

Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026

Indeterminate GlobeNewswire

5 hours ago

Kaléo Awarded $96.1 Million BARDA Contract to Advance 2-PAM Auto-Injector for U.S. Chemical Threat Preparedness

Indeterminate GlobeNewswire

5 hours ago

Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants

Indeterminate GlobeNewswire

5 hours ago

Atsena Presents Positive Preliminary Safety and Efficacy Results from Parts A and B of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire

5 hours ago

Cerevance Announces Positive Phase 3 ARISE Results: Once-daily Oral Solengepras Meets Primary Endpoint and Demonstrates Motor and Non-motor Benefits in Parkinson's Disease

Indeterminate GlobeNewswire

5 hours ago

Akebia Therapeutics to Conduct Investor Meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum

Indeterminate GlobeNewswire

6 hours ago

BrewDog Rallies Beer Lovers Across the UK to Choose Craft

Indeterminate GlobeNewswire

6 hours ago

Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes

Indeterminate GlobeNewswire

6 hours ago

CHARM Therapeutics announces first patient dosed and first cohort fully enrolled in its Phase I/II clinical trial of CHM-029 for Acute Myeloid Leukemia

Indeterminate GlobeNewswire

6 hours ago

OrthoPediatrics Expands Its Lower Extremity Bracing Portfolio with the Launch of OPSB® Knee 'TractorFIX

Indeterminate GlobeNewswire

6 hours ago

Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026

Indeterminate GlobeNewswire

6 hours ago

Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026

Indeterminate GlobeNewswire

6 hours ago

VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy

Indeterminate GlobeNewswire

6 hours ago

Cadrenal Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process to Maximize Value of its Orphan Thrombo-Inflammatory Therapeutics

Indeterminate GlobeNewswire